MCID: STR009
MIFTS: 13

Stromal Predominant Kidney Wilms' Tumor

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Stromal Predominant Kidney Wilms' Tumor

MalaCards integrated aliases for Stromal Predominant Kidney Wilms' Tumor:

Name: Stromal Predominant Kidney Wilms' Tumor 12
Stromal Predominant Kidney Wilms Tumor 17
Stromal Predominant Renal Wilms Tumor 12
Stromal Predominant Wilms' Tumor 74

Classifications:



External Ids:

Disease Ontology 12 DOID:5191
NCIt 51 C9148
UMLS 74 C0279610

Summaries for Stromal Predominant Kidney Wilms' Tumor

MalaCards based summary : Stromal Predominant Kidney Wilms' Tumor, is also known as stromal predominant kidney wilms tumor, and has symptoms including abdominal pain The drugs Carboplatin and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Stromal Predominant Kidney Wilms' Tumor

Symptoms & Phenotypes for Stromal Predominant Kidney Wilms' Tumor

UMLS symptoms related to Stromal Predominant Kidney Wilms' Tumor:


abdominal pain

Drugs & Therapeutics for Stromal Predominant Kidney Wilms' Tumor

Drugs for Stromal Predominant Kidney Wilms' Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
2
Etoposide Approved Phase 3 33419-42-0 36462
3
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
4
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
5
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
6
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
7
Doxil Approved June 1999 Phase 3 31703
8 Immunologic Factors Phase 3
9 Topoisomerase Inhibitors Phase 3
10 Antimitotic Agents Phase 3
11 Antineoplastic Agents, Alkylating Phase 3
12 Etoposide phosphate Phase 3
13 Alkylating Agents Phase 3
14 Antineoplastic Agents, Phytogenic Phase 3
15 Antibiotics, Antitubercular Phase 3
16 Nucleic Acid Synthesis Inhibitors Phase 3
17 Anti-Bacterial Agents Phase 3
18 Immunosuppressive Agents Phase 3
19 Anti-Infective Agents Phase 3
20 Antirheumatic Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor Unknown status NCT00047138 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate
2 Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer Completed NCT01353300

Search NIH Clinical Center for Stromal Predominant Kidney Wilms' Tumor

Genetic Tests for Stromal Predominant Kidney Wilms' Tumor

Anatomical Context for Stromal Predominant Kidney Wilms' Tumor

MalaCards organs/tissues related to Stromal Predominant Kidney Wilms' Tumor:

42
Kidney

Publications for Stromal Predominant Kidney Wilms' Tumor

Variations for Stromal Predominant Kidney Wilms' Tumor

Expression for Stromal Predominant Kidney Wilms' Tumor

Search GEO for disease gene expression data for Stromal Predominant Kidney Wilms' Tumor.

Pathways for Stromal Predominant Kidney Wilms' Tumor

GO Terms for Stromal Predominant Kidney Wilms' Tumor

Sources for Stromal Predominant Kidney Wilms' Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....